Pioglitazone, a PPAR Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1
Cancer Prevention Research - United States
doi 10.1158/1940-6207.capr-12-0201
Full Text
Open PDFAbstract
Available in full text
Date
July 10, 2012
Authors
Publisher
American Association for Cancer Research (AACR)